Drug recall · January 4, 2023
Timolol Maleate Ophthalmic Solution recall
Why: Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp. Weston, FL 33326, NDC 60505-1005-4
- Lots / codes
Lot# TA4844, Exp 03/2023
- Quantity
- 22,027 bottles
- Company
- Apotex Corp., Weston, FL
- Distribution
- USA Nationwide
- Initiated
- December 21, 2022 · Voluntary: Firm initiated
- Classified
- December 28, 2022
- Reported
- January 4, 2023
- Ended
- October 8, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.